Bortezomib Injection (Shilpa)
硼替佐米注射液 (Shilpa)
Report date: 2025/04/28 22:35:30
Base Information
Drug NameBortezomib Injection (Shilpa)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2024/09/05
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesShilpa Medicare Ltd
China Registration ClassN/A
Develop Information
Active CompaniesAmneal Pharmaceuticals IncShilpa Medicare Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A